Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition.

Oligofructose and inulin, naturally-occurring fermentable chicory fructans, have been shown to stimulate the growth of bifidobacteria which are regarded as beneficial strains in the colon and inhibit colon carcinogenesis in the laboratory animal models. The present study was designed to determine the effect of oligofructose and inulin on the azoxymethane (AOM)-induced preneoplastic lesions such as aberrant crypt foci (ACF) formation in the colon of male F344 rats. At 5 weeks of age, groups of animals were fed the AIN-76A (control) and the experimental diets containing 10% oligofructose or inulin. At 7 weeks of age, all animals received s.c. injection of AOM dissolved in normal saline at a dose rate of 15 mg/kg body wt, once weekly for 2 weeks. The animals were necropsied 7 weeks after the last AOM injection, and the ACF were visualized under light microscopy in the formalin-fixed, unsectioned methylene blue-stained colons. They were distinguished by their increased size, more prominent epithelial cells and pericryptal space. The feeding of oligofructose or inulin significantly inhibited the ACF formation and the crypt multiplicity in the colon. The degree of ACF inhibition was more pronounced in animals fed inulin than in those fed oligofructose. The findings suggest that chicory fructan supplements inhibit ACF formation, an early preneoplastic marker of malignant potential in the process of colon carcinogenesis.

[1]  G. Gibson,et al.  Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. , 1993, The Journal of applied bacteriology.

[2]  T. P. Pretlow,et al.  Aberrant crypts in human colonic mucosa: Putative preneoplastic lesions , 1992, Journal of cellular biochemistry. Supplement.

[3]  S. Gallinger,et al.  K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. , 1993, Carcinogenesis.

[4]  P. Wingo,et al.  Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.

[5]  M. Roberfroid,et al.  The biochemistry of oligofructose, a nondigestible fiber: an approach to calculate its caloric value. , 2009, Nutrition reviews.

[6]  T. Kirchner,et al.  Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. , 1992, Gastroenterology.

[7]  B. Reddy,et al.  Effect of dietary fiber on colonic bacterial enzymes and bile acids in relation to colon cancer. , 1992, Gastroenterology.

[8]  Bandaru S. Reddy,et al.  Dietary fiber and colon cancer: animal model studies. , 1987, Preventive medicine.

[9]  G R Gibson,et al.  Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. , 1995, The Journal of nutrition.

[10]  C. Denis-Pouxviel,et al.  Effects of short‐chain fatty acids on growth and differentiation of the human colon‐cancer cell line HT29 , 1992, International journal of cancer.

[11]  Y. Hashimoto,et al.  Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis. , 1995, Biological & pharmaceutical bulletin.

[12]  C. J. McGrath,et al.  Effect of exchange rate return on volatility spill-over across trading regions , 2012 .

[13]  F. Bornet,et al.  Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans. , 1996, Nutrition and cancer.

[14]  Bandaru S. Reddy,et al.  Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. , 1993, Cancer research.

[15]  A. Medline,et al.  Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. , 1991, Cancer research.

[16]  J. Rumessen,et al.  Fructans of Jerusalem artichokes: intestinal transport, absorption, fermentation, and influence on blood glucose, insulin, and C-peptide responses in healthy subjects. , 1990, The American journal of clinical nutrition.

[17]  T. P. Pretlow,et al.  Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. , 1992, Carcinogenesis.

[18]  M. Roberfroid,et al.  The bifidogenic nature of chicory inulin and its hydrolysis products. , 1998, The Journal of nutrition.

[19]  S. Sugie,et al.  Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. , 1988, Cancer research.

[20]  Bandaru S. Reddy,et al.  Inhibitory Effect of Bifidobacterium Iongum Cultures on the Azoxymethane-Induced Aberrant Crypt Foci Formation and Fecal Bacterial β-Glucuronidase , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[21]  M. Roberfroid,et al.  Growth inhibition of transplantable mouse tumors by non‐digestible carbohydrates , 1997, International journal of cancer.

[22]  V. Steele,et al.  Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  J. Lupton,et al.  Butyrate as a differentiating agent: pharmacokinetics, analogues and current status. , 1994, Cancer letters.

[24]  G R Gibson,et al.  Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. , 1995, Gastroenterology.

[25]  T. Campbell,et al.  The effect of quantity and quality of dietary protein on drug metabolism. , 1976, Federation proceedings.